Korea to Launch First GLP-1 Obesity Drug Eppe on October 29 | Retatrutide News

Korea will launch its first GLP-1 obesity drug, Eppe, on October 29. This marks a significant step in Korea's participation in the GLP-1 agonist market.
Market News · October 23, 2026